The Drug-Drug Interactions Ontology

Last uploaded: February 11, 2016
Id http://purl.obolibrary.org/obo/dinto_DB06207
http://purl.obolibrary.org/obo/dinto_DB06207
Preferred Name

silodosin
Synonyms
C25H32F3N3O4
1-(3-hydroxypropyl)-5-[(2R)-2-({2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl}amino)propyl]-2,3-dihydro-1H-indole-7-carboxamide
Type http://www.w3.org/2002/07/owl#Class

All Properties

prefLabel
silodosin
label
silodosin
DBSynonym
kad 3213
kmd 3213
ATCCode
G04CA04
Definition
Silodosin is an ?1-adrenoceptor antagonist that is selective for the prostate. Silodosin is for symptomatic treatment of benign prostatic hyperplasia. FDA approved Oct 9, 2008.
has effect
has pharmacological target
type
InChIKey
InChIKey=PNCPYILNMDWPEY-QGZVFWFLSA-N
is metabolised by
blocks
Synonym
C25H32F3N3O4
1-(3-hydroxypropyl)-5-[(2R)-2-({2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl}amino)propyl]-2,3-dihydro-1H-indole-7-carboxamide
xref
Drugs.com:http://www.drugs.com/cdi/silodosin.html
PharmGKB:PA165291889
ChemSpider:4471557
Wikipedia:http://en.wikipedia.org/wiki/Silodosin
RxList:http://www.rxlist.com/rapaflo-capsules-drug.htm
PubChem Compound:5312125
National Drug Code Directory:54868-6173-0
BindingDB:50160154
PubChem Substance:7849027
See more
See less
CASRN
160970-54-7
prefixIRI
obo2:dinto_DB06207
is transported by
SMILES
C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F
may interact with
InChI
InChI=1S/C25H32F3N3O4/c1-17(30-8-12-34-21-5-2-3-6-22(21)35-16-25(26,27)28)13-18-14-19-7-10-31(9-4-11-32)23(19)20(15-18)24(29)33/h2-3,5-6,14-15,17,30,32H,4,7-13,16H2,1H3,(H2,29,33)/t17-/m1/s1
DBBrand
rapilif
silodyx
rapaflo
urief
subClassOf
Add comment
Add proposal
Delete Subject Author Type Created
No notes to display